The association of low complement with disease activity in systemic sclerosis: a prospective cohort study. Issue 1 (December 2016)
- Record Type:
- Journal Article
- Title:
- The association of low complement with disease activity in systemic sclerosis: a prospective cohort study. Issue 1 (December 2016)
- Main Title:
- The association of low complement with disease activity in systemic sclerosis: a prospective cohort study
- Authors:
- Esposito, James
Brown, Zoe
Stevens, Wendy
Sahhar, Joanne
Rabusa, Candice
Zochling, Jane
Roddy, Janet
Walker, Jennifer
Proudman, Susanna
Nikpour, Mandana - Abstract:
- Abstract Background In some rheumatic diseases such as systemic lupus erythematosus (SLE), low serum complement ('hypocomplementaemia') is a feature of active disease. However, the role of hypocomplementaemia in systemic sclerosis (SSc) is unknown. We sought to determine the frequency, clinical associations and relationship to disease activity of hypocomplementaemia in SSc. Methods The study included 1140 patients fulfilling the 2013 American College of Rheumatology criteria for SSc. Demographic, serological and clinical data, obtained prospectively through annual review, were analysed using univariable methods. Linear and logistic regression, together with generalised estimating equations, were used to determine the independent correlates of hypocomplementaemia ever, and at each visit, respectively. Results At least one episode of hypocomplementaemia (low C3 and/or low C4) occurred in 24.1 % of patients over 1893 visits; these patients were more likely to be seropositive for anti-ribonucleoprotein (OR = 3.8, p = 0.002), anti-Ro (OR = 2.2, p = 0.002), anti-Smith (OR = 6.3, p = 0.035) and anti-phospholipid antibodies (OR = 1.4, p = 0.021) and were more likely to display features of overlap connective tissue disease, in particular polymyositis (OR = 16.0, p = 0.012). However, no association was found between hypocomplementaemia and either the European Scleroderma Study Group disease activity score or any of its component variables (including erythrocyte sedimentationAbstract Background In some rheumatic diseases such as systemic lupus erythematosus (SLE), low serum complement ('hypocomplementaemia') is a feature of active disease. However, the role of hypocomplementaemia in systemic sclerosis (SSc) is unknown. We sought to determine the frequency, clinical associations and relationship to disease activity of hypocomplementaemia in SSc. Methods The study included 1140 patients fulfilling the 2013 American College of Rheumatology criteria for SSc. Demographic, serological and clinical data, obtained prospectively through annual review, were analysed using univariable methods. Linear and logistic regression, together with generalised estimating equations, were used to determine the independent correlates of hypocomplementaemia ever, and at each visit, respectively. Results At least one episode of hypocomplementaemia (low C3 and/or low C4) occurred in 24.1 % of patients over 1893 visits; these patients were more likely to be seropositive for anti-ribonucleoprotein (OR = 3.8, p = 0.002), anti-Ro (OR = 2.2, p = 0.002), anti-Smith (OR = 6.3, p = 0.035) and anti-phospholipid antibodies (OR = 1.4, p = 0.021) and were more likely to display features of overlap connective tissue disease, in particular polymyositis (OR = 16.0, p = 0.012). However, no association was found between hypocomplementaemia and either the European Scleroderma Study Group disease activity score or any of its component variables (including erythrocyte sedimentation rate) in univariate analysis. Among patients with SSc overlap disease features, those who were hypocomplementaemic were more likely to have digital ulcers (OR = 1.6, p = 0.034), tendon friction rubs (OR = 2.4, p = 0.037), forced vital capacity <80 % predicted (OR = 2.9, p = 0.008) and lower body mass index (BMI) (OR for BMI = 0.9, p < 0.0005) at that visit, all of which are features associated with SSc disease activity and/or severity. Conclusions While hypocomplementaemia is not associated with disease activity in patients with non-overlap SSc, it is associated with some features of increased SSc disease activity in patients with overlap disease features. … (more)
- Is Part Of:
- Arthritis research & therapy. Volume 18:Issue 1(2016)
- Journal:
- Arthritis research & therapy
- Issue:
- Volume 18:Issue 1(2016)
- Issue Display:
- Volume 18, Issue 1 (2016)
- Year:
- 2016
- Volume:
- 18
- Issue:
- 1
- Issue Sort Value:
- 2016-0018-0001-0000
- Page Start:
- 1
- Page End:
- 12
- Publication Date:
- 2016-12
- Subjects:
- Systemic sclerosis -- Complement -- Disease activity
Arthritis -- Periodicals
Arthritis -- Treatment -- Periodicals
616.722005 - Journal URLs:
- http://arthritis-research.com ↗
http://pubmedcentral.gov/tocrender.fcgi?journal=135 ↗
http://link.springer.com/ ↗ - DOI:
- 10.1186/s13075-016-1147-2 ↗
- Languages:
- English
- ISSNs:
- 1478-6362
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 9948.xml